International Society of Paediatric Oncology (SIOP) Global Mapping Programme: Latin American Society of Pediatric Oncology (SLAOP) country-level report


Por: Cappellano A, Gorostegui M, Gonzalez-Ramella O, Filho NPC, Valencia D, Chantada L, Sampor C, Serrano MJ, Macedo C, Ramirez O, Sardinas S, Lezcano E, Calderón P, Gamboa Y, Fu L, Gómez W, Schelotto M, Ugaz C, Lobos P, Aguiar SDS, Moreno K, Palma J, Sánchez G, Moschella F, Gassant PYH, Velasquez T, Quintero K, Moreno F, Villarroel M, Fuentes Alabi S, Vasquez L, Challinor J and Chantada G

Publicada: 1 jun 2024 Ahead of Print: 1 mar 2024
Resumen:
BackgroundLatin American countries are improving childhood cancer care, showing strong commitment to implement the Global Initiative for Childhood Cancer, but there are scant publications of the situation at a continental level.MethodsAs part of the International Society of Paediatric Oncology Global Mapping project, delegates of each country participating in the Latin American Society of Pediatric Oncology (SLAOP) and chairs of national pediatric oncology societies and cooperative groups were invited to provide information regarding availability of national pediatric cancer control programs (NPCCP), pediatric oncology laws, pediatric oncology tumor registries, and training programs and support to diagnosis and treatment.ResultsNineteen of the 20 countries participating in SLAOP responded. National delegates reported nine countries with NPCCP and four of them were launched in the past 5 years. National pediatric tumor registries are available in eight countries, and three provided published survival results. Fellowship programs for training pediatric oncologists are available in 12 countries. National delegates reported that eight countries provide support to most essential diagnosis and treatments and 11 provide partial or minimal support that is supplemented by civil society organizations. Seven countries have a pediatric oncology law. There are three international cooperative groups and four national societies for pediatric oncology.ConclusionDespite many challenges, there were dramatic advances in survivorship, access to treatment, and availability of NPCCP in Latin America. Countries with highest social development scores in general provide more complete support and are more likely to have NPCCP, training programs, and reported survival results.

Filiaciones:
Cappellano A:
 Institute of Pediatric Oncology (IOP/GRAACC), São Paulo, Brazil

Gorostegui M:
 Hospital Sant Joan de Déu, Pediatric Cancer Center Barcelona (PCCB), Barcelona, Spain

Gonzalez-Ramella O:
 Hospital Civil de Guadalajara Dr Juan I. Menchaca, Guadalajara, Mexico

Filho NPC:
 Hospital Santa Marcelina/TUCAA, SOBOPE (Sociedade Brasileira de Oncologia Pediátrica), São Paulo, Brazil

Valencia D:
 Department of Pediatric Oncology, IMAT Oncomedica AUNA, Monteria, Hospital Universitario de Santander, Bucaramanga, Colombia

Chantada L:
 Hospital Italiano, Buenos Aires, Argentina

Sampor C:
 Hospital JP Garrahan, Buenos Aires, Argentina

Serrano MJ:
 Clínica Foscal, Floridablanca, Santander, Colombia

Macedo C:
 Institute of Pediatric Oncology (IOP/GRAACC), São Paulo, Brazil

Ramirez O:
 Fundación POHEMA, Cali, Colombia

Sardinas S:
 Hospital del Niño Dr Ovidio Aliaga Uria, La Paz, Bolivia

Lezcano E:
 Hospital Central Del Instituto de Previsión Social (IPS), Asunción, Paraguay

Calderón P:
 Hospital Infantil Manuel de Jesús Rivera, Managua, Nicaragua

Gamboa Y:
 Oncology Unit, National Children's Hospital, San José, Costa Rica

Fu L:
 Hospital Escuela, Tegucigalpa, Honduras

Gómez W:
 National Cancer Institute-INCART, Santo Domingo, Dominican Republic

Schelotto M:
 Hospital Pereira Rosell Fundación Perez-Scremini, Montevideo, Uruguay

Ugaz C:
 Instituto Nacional de Enfermedades Neoplasicas, Lima, Perú

Lobos P:
 Hospital Italiano, Buenos Aires, Argentina

Aguiar SDS:
 Institute of Pediatric Oncology (IOP/GRAACC), São Paulo, Brazil

Moreno K:
 Hospital Verdi Cevallos Balda, Portoviejo, Ecuador

Palma J:
 Hospital Dr Luis Calvo Mackenna, Santiago, Chile

Sánchez G:
 Hospital SOLCA and Hospital Metropolitano, Quito, Ecuador

Moschella F:
 Hospital Universitario Dr Luis Razetti, Barcelona Edo Anzoategui, Barcelona, Venezuela

Gassant PYH:
 Nos Petits Frères et Sœurs/Hôpital Saint-Damien, Port Au Prince, Haiti

Velasquez T:
 Unidad Nacional de Oncologia Pediátrica (UNOP), Guatemala City, Guatemala

Quintero K:
 Children's Hospital Dr Jose Renan Esquivel, Panama City, Panama

Moreno F:
 Instituto Nacional del Cancer, Buenos Aires, Argentina

Villarroel M:
 Hospital Dr Luis Calvo Mackenna, Santiago, Chile

Fuentes Alabi S:
 Hospital Nacional de Ninos Benjamin Bloom y Centro Medico Ayudame a Vivir, San Salvador, El Salvador

Vasquez L:
 Department of Noncommunicable Diseases and Mental Health, Unit of Noncommunicable Diseases, Pan American Health Organization/World Health Organization, Washington, District of Columbia, USA

Challinor J:
 University of California San Francisco, San Francisco, California, USA

Chantada G:
 Hospital Sant Joan de Déu, Pediatric Cancer Center Barcelona (PCCB), Barcelona, Spain

 Hospital Pereira Rosell Fundación Perez-Scremini, Montevideo, Uruguay
ISSN: 15455009





PEDIATRIC BLOOD & CANCER
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ, Estados Unidos America
Tipo de documento: Article
Volumen: 71 Número: 6
Páginas:
WOS Id: 001195283200001
ID de PubMed: 38556746

FULL TEXT

imagen Accepted Version https://www.wiley.com/en-us/network/publishing/research-publishing/open-access/copyright-and-licensing-with-wiley

MÉTRICAS